Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic ApproachesRobert Pollmann, Michael Hertl, Thomas Schmidt et al.|Clinical Reviews in Allergy & Immunology|2018Cited by 191
Therapeutic Targeting of Th17/Tc17 Cells Leads to Clinical Improvement of Lichen PlanusFarzan Solimani, Michael Hertl, Robert Pollmann et al.|Frontiers in Immunology|2019Cited by 116
Immunophenotyping in pemphigus reveals a TH17/TFH17 cell–dominated immune response promoting desmoglein1/3-specific autoantibody productionJulia Holstein, Christian Möbs, Farzan Solimani et al.|Journal of Allergy and Clinical Immunology|2020Cited by 95
TH1/TH17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planusThomas Schmidt, Michael Hertl, Farzan Solimani et al.|Journal of Allergy and Clinical Immunology|2018Cited by 83
Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with PemphigusTina Hennerici, Rüdiger Eming, Björn Tackenberg et al.|PLoS ONE|2016Cited by 73